Background Individual risk of recurrent venous thromboembolism affects patient
management and might differ between men and women. We did a meta-analysis to assess …

Objective To determine the effect of sex on the risk of recurrent venous thromboembolism in
all patients and in patients with venous thromboembolism that was unprovoked or provoked …

Objectives To determine the rate of a first recurrent venous thromboembolism (VTE) event
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …

Background: We have analyzed the influence of gender on risk of recurrence after a first
episode of venous thromboembolism (VTE). Methods: The Cambridge Venous …

Background Whether a patient's sex is associated with the risk of recurrent venous
thromboembolism is unknown. Methods We studied 826 patients for an average of 36 …

Background: Whether to continue oral anticoagulant therapy beyond 6 months after an
“unprovoked” venous thromboembolism is controversial. We sought to determine clinical …

Randomized controlled trials are the optimal study design to compare management
strategies, including comparisons of different durations of anticoagulant therapy for venous …

ContextPatients with venous thromboembolism (VTE) are susceptible to recurrent events,
but whether prolonging anticoagulation is warranted in patients with VTE remains …

Background The long‐term risk for recurrent venous thromboembolism (VTE) during
extended anticoagulation for a first unprovoked VTE is uncertain. Objectives To determine …

Background The optimal duration of anticoagulation for women who had venous
thromboembolism (VTE) associated with estrogen use is unknown. Objectives To test the …